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Summary 
 
Nuclear receptors (NRs) are a large family of ligand-induced transcription factors that 
includes the vitamin D receptor. The recent discovery of WINAC, a novel ATP-dependent 
chromatin remodeling complex, has shed new light about the molecular mechanisms by 
which the vitamin D receptor control gene expression with unexpected clinical 
implications. 
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In eukaryotic organisms, the packaging of DNA in the form of nucleosomes to 
generate chromatin is an effective way of storing DNA inside the cell nucleus but it poses 
formidable problems for the transcription of genes and the replication of the genome. The 
formation of a tightly packed chromatin fiber leads to a repressive environment that has to 
be overcome to allow these essential functions to take place. This is achieved by a rather 
ill-defined process termed chromatin remodeling that regulates the accessibility of gene 
promoters to the transcription and replication machinery. The number of chromatin 
remodeling enzymes is extensive but they can be divided into two distinct classes, both of 
which contribute to the generation of a dynamic chromatin structure. First, there are ATP-
dependent complexes that are involved in the location and association of nucleosomes with 
DNA and second there are enzymes that catalyze post-translational modifications in 
histones. Such modifications are proposed to constitute a ‘histone code’ that represents an 
epigenetic marking mechanism for controlling gene transcription and other chromatin-
regulated processes (Jenuwein and Allis, 2001).  
The progress made in identifying chromatin remodeling complexes over the past 
decade has been astonishing. Additional complexes continue to be discovered, including a 
novel ATP-dependent remodeling complex, termed WINAC, described recently by Kato 
and coworkers in Cell to play a role in vitamin D action (Kitagawa et al., 2003). Despite 
many advances in the characterization of remodeling complexes fundamental questions 
remain to be answered. For example, the rules that govern which remodeling complexes are 
required to regulate the transcription of specific sets of genes remain to be established, 
details of their mode of recruitment are just emerging but the kinetics of the process are 
controversial and little is known about their precise function in regulating transcription 
from endogenous genes. Studies in yeast are clearly the most tractable and they are 
providing a basic understanding of the fundamental principles of transcriptional regulation. 
Studies in higher eukaryotic organisms are more complex but a number of hormonally and 
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developmentally regulated genes are amenable to a detailed analysis using cell-free 
reconstitution assays, mouse models and, very occasionally, clinical observations. The 
ability of hormones to trigger the activation or repression of NRs provides an ideal 
opportunity for investigating the transcription of specific target genes both in vitro and in 
vivo. 
NRs comprise a family of ligand-dependent transcription factors that includes the 
vitamin D receptor. Over the past ten years many cofactors implicated in their 
transcriptional regulation have been identified (McKenna and O’Malley, 2002) (Table 1). 
Amongst the best characterized are the p160 coactivators which seem to serve as platforms 
for the recruitment of histone modifying enzymes, including CBP/p300 and 
methyltransferases that acetylate or methylate histones, respectively. The p160 proteins 
have been found to interact directly with an activation surface, called AF2, located in the 
ligand binding domain of NRs. Similarly, a number of corepressor proteins such as NCoR, 
SMRT, RIP140 and LCoR may also be recruited to this surface of the receptor, dependent 
on the ligand bound. They too seem to function as platforms, but serve to recruit enzymes 
such as histone deacetylases or redox sensing cofactors including C-terminal binding 
protein (CtBP). The nature of the cofactors recruited to a target promoter is envisioned to 
determine its transcriptional activity. 
A role for ATP-dependent chromatin remodeling complexes in transcriptional 
regulation by steroid receptors was first proposed by Yamamoto (Yoshinaga et al. 1992) 
and substantiated by Yaniv (Murchard and Yaniv, 1993). The precise number of ATP-
dependent chromatin remodeling complexes is unknown but there are at least four families 
each containing a distinct core ATPase subunit, SWI/SNF, ISWI, CHD and INO80 (Becker 
and Hörz, 2002). To this list must be added the WINAC complex, which shares subunits 
with two distinct family members, SWI/SNF and ISWI. They function as multiprotein 
complexes comprising up to 10-12 subunits with roles not only in gene transcription but 
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also in DNA replication, DNA repair and recombination. The SWI/SNF and ISWI families 
are the two best characterized ATP-dependent chromatin remodeling complexes. Both 
classes have been shown to induce nucleosome sliding along DNA, although their 
biological functions and biochemical activities are different. In addition, SWI/SNF can 
cause conformational changes in DNA on the surface of the nucleosome and it can remodel 
topologically constrained chromatin templates. An interaction between the glucocorticoid 
receptor and the SWI/SNF remodeling complex was demonstrated by Archer (Fryer and 
Archer, 1998) and this was subsequently found to be mediated by BAF250, a subunit, 
present only in a subset of SWI/SNF complexes (Nie et al., 2000). The estrogen receptor 
has been found to interact with another component found in all SWI/SNF remodeling 
complexes, namely BAF57, (Belandia et al., 2002) and this appears to be essential for the 
ability of the p160 proteins to potentiate transcription from estrogen-responsive reporter 
genes. 
Several lines of evidence indicate a close functional link between SWI/SNF 
complexes and histone acetyltransferases. While SWI/SNF can be recruited directly to 
chromatin by transcription factors, the acetylation of histone tails has been found to 
stabilize its binding to nucleosomes. This strong interaction, which is mediated by a 
bromodomain, can then be maintained even in the absence of the transcription factor that 
initially recruited the coactivator complex (Jenuwein and Allis 2001, Hassan et al., 2002). 
The functions of a number of remodeling complexes in transcriptional regulation by NRs 
has been examined in chromatin-dependent transcription assays (Dilworth et al., 2000, 
Lemon et al., 2001, Huang et al., 2003). Interestingly, Chambon and coworkers found that 
the ability of retinoid receptors to stimulate transcription depended on the sequential action 
of a number of remodeling complexes, starting with ISWI, followed by histone 
aceltyltransferases, specifically a p160-CBP/p300 complex, and finally SWI/SNF. This 
observation therefore supports the view that histone acetylation is required for remodeling 
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chromatin by the SWI/SNF complex. A functional link between the two families of 
coactivators is also evident from the recent analysis of their function in promoting the 
transcriptional activity of both the androgen and the thyroid hormone receptors (Huang et 
al., 2003). Wong and coworkers confirmed that the p160 proteins are necessary for the 
recruitment of CBP/p300 but then demonstrate that these alone do not lead to chromatin 
remodeling but rather to the recruitment of SWI/SNF which is capable of inducing 
chromatin remodeling. Thus it appears that there are multiple protein-protein interactions 
between coactivators and NRs and between coactivators themselves. A distinct ATP-
dependent remodeling complex has been found to repress gene transcription, namely 
NURD, a member of the chromodomain family of complexes. NURD contains at least two 
HDACs and is recruited to the estrogen receptor by means of MTA1, an integral 
component of the complex, whereupon it repressed ligand-dependent transcription by the 
estrogen receptor (Mazumdar et al., 2000). 
In a recent issue of Cell, Kitagawa et al. describe a novel multi-functional ATP-
dependent chromatin remodeling complex called WINAC that interacts directly with the 
vitamin D receptor. WINAC represents a new member of the SWI/SNF subfamily with 
unique characteristics. It contains BRG1 or hBRM as ATPase subunits like all SWI/SNF 
complexes, but it also has subunits associated with DNA replication (TopoIIβ, and CAF-
1p150) and transcript elongation through nucleosomes (FACTp140) not found before in 
SWI/SNF complexes. In addition, WINAC also contains the Williams syndrome 
transcription factor (WSTF). The WSTF gene is deleted in patients with Williams 
syndrome, a complex neurodevelopmental disorder caused by heterozygous deletions of 1.6 
Mb at chromosome 7q11.23. This syndrome is characterized by congenital vascular and 
heart disease, dysmorphic facies, mental retardation, growth retardation, infantile abnormal 
vitamin D metabolism and hypercalcemia (Morris and Mervis, 2000). WSTF, like the 
closely related ACF1, was recently reported to be associated with hISWI (otherwise known 
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as hSNFH and hSNFL) forming a distinct ATP-dependent chromatin remodeling complex 
termed WICH (Bozhenok et al., 2002). WICH and other ISWI complexes mobilize 
nucleosomes and create regular nucleosomal arrays from irregular chromatin. WINAC 
promotes both the assembly and disruption of nucleosome arrays in an ATP-dependent 
manner and in addition, like the CAF-1 histone chaperone complex, it can also reconstitute 
chromatin upon newly replicated DNA. 
WSTF appears to function as a platform protein for the assembly of components in 
WINAC and it is also capable of interacting directly with the vitamin D receptor. The 
interaction between vitamin D receptor and WINAC occurs in a ligand-independent 
manner, in contrast to that between glucocorticoid receptor-BAF250 and estrogen receptor-
BAF57, which are promoted by ligand binding. Chromatin immunoprecipitation 
experiments confirmed that WINAC and vitamin D receptor are targeted to vitamin D 
responsive promoters in the absence of ligand, interestingly to both positively and 
negatively regulated genes. Manipulation of the levels of WSTF expression established that 
this subunit is essential for vitamin D receptor both to stimulate transcription from 
promoters regulated by positive response elements and repress transcription from promoters 
containing negative response elements. The molecular basis for this dual function is 
unknown but it is conceivable that the sequence of the individual positive and negative 
vitamin D receptor response elements might act as an allosteric effector of receptor 
conformation (Koszewski et al., 1999), facilitating the binding of distinct enzymatic 
activities associated with coactivators or corepressors. WINAC, like other SWI/SNF and 
ISWI complexes, seems to be able to reorganize the chromatin fiber either way, opening the 
structure to allow transcription or compacting it to repress gene expression. 
Vitamin D is essential for mineral homeostasis, skeletal integrity and control of cell 
growth and differentiation in many tissues (Sutton and MacDonald, 2003). Ascribing 
Williams syndrome abnormalities to defects in the ability of vitamin D receptor to regulate 
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transcription is difficult and complicated by the fact that the syndrome is caused by 
heterozygous deletions of 1.6 Mb, which includes not only WSTF but also at least 15, other 
genes. In fact, given a defect in vitamin D signaling, certain features such as hypercalcemia 
are paradoxical because one of the functions of vitamin D is to promote calcium uptake. 
However this might be explained by the observation that WSTF is required for the 
expression of enzymes involved in both the synthesis and the catabolism of vitamin D. An 
abnormal vitamin D receptor function could be also at the root of some of the 
cardiovascular problems. Haploinsuffienciency for elastin gene seems to be the main cause 
of the arterial pathology, however its expression is dependent on vitamin D intake (Li et al., 
1998 and references therein). Therefore, impaired vitamin D receptor function could 
contribute to the generation of a more severe cardiovascular disease. At the present time it 
is not be possible to draw definitive conclusions about the contribution of vitamin D 
receptor signaling to the abnormalities observed in Williams syndrome patients, but a 
comparative analysis of mice with tissue specific deletions of vitamin D receptor and 
WSTF alleles should help to elucidate their biological roles and may provide insights into 
certain aspects of Williams syndrome. 
Our understanding of the function of NRs has been dramatically advanced over the 
past decade by using biochemical approaches to investigate structure-function relationships 
and by studying genetically manipulated mice, particularly gene deletions. Tremendous 
progress has also been made to elucidate the function of chromatin remodeling complexes 
in transcriptional regulation, particularly using reconstituted systems, and the biological 
roles of these complexes are beginning to emerge from studies of mice devoid of specific 
genes. However, functional redundancy is a confounding factor and interpreting the 
phenotypes is often not straightforward especially for those coactivators with global effects. 
Nevertheless, by focusing on key target genes for NRs, further advances will undoubtedly 
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be made. The challenge therefore will be to use these clues to determine the origin of many 
human diseases and help to develop therapeutic strategies. 
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Figure legend 
 
Figure 1. Proposed models for the contribution of WSTF haploinsufficieny to Williams 
syndrome phenotype. WSTF, when incorporated into WINAC, is required for the 
transcriptional regulation by vitamin D receptors (VDR) both in negatively (A) and 
positively (B) regulated target genes. WINAC mediates the recruitment of unliganded 
vitamin D receptor to vitamin D response elements (VDREs) while subsequent binding of 
coregulators requires ligand binding. It is not known yet whether WINAC and other 
coregulators interact simultaneously or sequentially with the vitamin D receptor. Aberrant 
expression of WSTF can affect the recruitment of WINAC and other chromatin modifying 
enzymes to vitamin D responsive genes, altering both basal and hormone-dependent gene 
expression. As a consequence of defective vitamin D signaling, calcium and vitamin D 
metabolism in addition to many other metabolic processes will be disturbed. Insufficient 
WSTF in the cell might also impair DNA replication (C), which requires WINAC and the 
WICH complex (hISWI-WSTF), affecting cell cycle regulation and/or chromosome 
stability. The effects on transcriptional control and DNA replication are not mutually 
exclusive and both could contribute to the complex phenotype observed in Williams 
syndrome patients. For more details see text and Table 1. 
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Table 1.  Protein interactions recruiting chromatin modifying activities to nuclear receptors	
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